CrossrefInfokarte
Modeling Systemic Lupus Erythematosus Treatment Cost-Effectiveness Based on a Novel Lupus Low Disease Activity State Treat-to-Target Approach
Value in Health · 2026-11 · 29 (11) · 2025-2034
DOI: 10.1016/j.jval.2026.06.014 ↗Abstract
Kein Abstract verfügbar.
EUVIMED